Levothyroxine Exhibits Inhibitory Effect towards UDP-Glucuronosyltransferase (UGT) 1A6-Mediated 4-Methylumbelliferone (4-MU) Glucuronidation
Levothyroxine, a synthetic form of thyroid hormone, has been clinically used to treat thyroid hormone deficiency. UDP-glucuronosyltransferases (UGTs) are important phase II drug-metabolizing enzymes, and UGTs-inhibition based drug-drug interaction has been widely reported. The aim of the present stu...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Articulo Comunicacion |
| Lenguaje: | Inglés |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/20228 http://www.latamjpharm.org/resumenes/31/5/LAJOP_31_5_2_1.pdf |
| Aporte de: |
| id |
I19-R120-10915-20228 |
|---|---|
| record_format |
dspace |
| institution |
Universidad Nacional de La Plata |
| institution_str |
I-19 |
| repository_str |
R-120 |
| collection |
SEDICI (UNLP) |
| language |
Inglés |
| topic |
Farmacia Glucuronosiltransferasa Drug-drug interaction Levothyroxine UDP-glucuronosyltransferases (UGTs) |
| spellingShingle |
Farmacia Glucuronosiltransferasa Drug-drug interaction Levothyroxine UDP-glucuronosyltransferases (UGTs) Wang, Chuan-Qiang Song, Ming-Zhu Zhu, Hou-Wei Yi, Jia-Jun Luan, Ming-Chun Shi, Ai-Yuan Qu, Yan-Qing Levothyroxine Exhibits Inhibitory Effect towards UDP-Glucuronosyltransferase (UGT) 1A6-Mediated 4-Methylumbelliferone (4-MU) Glucuronidation |
| topic_facet |
Farmacia Glucuronosiltransferasa Drug-drug interaction Levothyroxine UDP-glucuronosyltransferases (UGTs) |
| description |
Levothyroxine, a synthetic form of thyroid hormone, has been clinically used to treat thyroid hormone deficiency. UDP-glucuronosyltransferases (UGTs) are important phase II drug-metabolizing enzymes, and UGTs-inhibition based drug-drug interaction has been widely reported. The aim of the present study is to investigate the inhibitory effect of levothyroxine towards UGT1A6-catalyzed 4-methylumbelliferone (4-MU) glucuronidation. The results showed that levothyroxine inhibited UGT1A6-catalyzed 4-MU glucuronidation reaction in a dose-dependent manner. Furthermore, Lineweaver-Burk and Dixon plots showed the inhibition of UGT1A6 by levothyroxine was best fit to competitive inhibition, and the inhibition kinetic parameter (Ki ) was determined to be 15.3 μM. Given that UGT1A6 is one of the most important UGT isoforms catalyzing the glucuronidation reaction of many important clinical drugs, including aspirin and serotonin, inhibition of UGT1A6 activity by levothyroxine will significantly influence the pharmacokinetic behaviour of these drugs. Therefore, clinical drug-drug interaction due to the inhibition of UGT1A6 by levothyroxine should paid much attention. |
| format |
Articulo Comunicacion |
| author |
Wang, Chuan-Qiang Song, Ming-Zhu Zhu, Hou-Wei Yi, Jia-Jun Luan, Ming-Chun Shi, Ai-Yuan Qu, Yan-Qing |
| author_facet |
Wang, Chuan-Qiang Song, Ming-Zhu Zhu, Hou-Wei Yi, Jia-Jun Luan, Ming-Chun Shi, Ai-Yuan Qu, Yan-Qing |
| author_sort |
Wang, Chuan-Qiang |
| title |
Levothyroxine Exhibits Inhibitory Effect towards UDP-Glucuronosyltransferase (UGT) 1A6-Mediated 4-Methylumbelliferone (4-MU) Glucuronidation |
| title_short |
Levothyroxine Exhibits Inhibitory Effect towards UDP-Glucuronosyltransferase (UGT) 1A6-Mediated 4-Methylumbelliferone (4-MU) Glucuronidation |
| title_full |
Levothyroxine Exhibits Inhibitory Effect towards UDP-Glucuronosyltransferase (UGT) 1A6-Mediated 4-Methylumbelliferone (4-MU) Glucuronidation |
| title_fullStr |
Levothyroxine Exhibits Inhibitory Effect towards UDP-Glucuronosyltransferase (UGT) 1A6-Mediated 4-Methylumbelliferone (4-MU) Glucuronidation |
| title_full_unstemmed |
Levothyroxine Exhibits Inhibitory Effect towards UDP-Glucuronosyltransferase (UGT) 1A6-Mediated 4-Methylumbelliferone (4-MU) Glucuronidation |
| title_sort |
levothyroxine exhibits inhibitory effect towards udp-glucuronosyltransferase (ugt) 1a6-mediated 4-methylumbelliferone (4-mu) glucuronidation |
| publishDate |
2012 |
| url |
http://sedici.unlp.edu.ar/handle/10915/20228 http://www.latamjpharm.org/resumenes/31/5/LAJOP_31_5_2_1.pdf |
| work_keys_str_mv |
AT wangchuanqiang levothyroxineexhibitsinhibitoryeffecttowardsudpglucuronosyltransferaseugt1a6mediated4methylumbelliferone4muglucuronidation AT songmingzhu levothyroxineexhibitsinhibitoryeffecttowardsudpglucuronosyltransferaseugt1a6mediated4methylumbelliferone4muglucuronidation AT zhuhouwei levothyroxineexhibitsinhibitoryeffecttowardsudpglucuronosyltransferaseugt1a6mediated4methylumbelliferone4muglucuronidation AT yijiajun levothyroxineexhibitsinhibitoryeffecttowardsudpglucuronosyltransferaseugt1a6mediated4methylumbelliferone4muglucuronidation AT luanmingchun levothyroxineexhibitsinhibitoryeffecttowardsudpglucuronosyltransferaseugt1a6mediated4methylumbelliferone4muglucuronidation AT shiaiyuan levothyroxineexhibitsinhibitoryeffecttowardsudpglucuronosyltransferaseugt1a6mediated4methylumbelliferone4muglucuronidation AT quyanqing levothyroxineexhibitsinhibitoryeffecttowardsudpglucuronosyltransferaseugt1a6mediated4methylumbelliferone4muglucuronidation |
| bdutipo_str |
Repositorios |
| _version_ |
1764820465500553217 |